Community curated by people like you

Orchestra Bio stories

Oct 20, 2026

OpenAI acquires Orchestra Bio to expand into pharmaceutical AI

OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development. The acquisition signals OpenAI's expansion into the healthcare sector, following rival Anthropic's similar moves.

Oct 20, 2026·3 sources

00

Top claims

▪OpenAI acquired four-year-old AI biotech software startup Orchestra Bio on October 20, 2026
▪Anthropic acquired AI biotech startup Coefficient Bio for approximately $400 million in April 2026
▪Anthropic established a biological research lab in September 2026 and reported that Claude helped identify a novel enzyme system similar to CRISPR

Topics

OpenAI's acquisition of Orchestra Bio AI Industry OpenAI Drug discovery AI in healthcare Mergers & acquisitions (M&A)AI applications AI drug discovery AI agents